<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>1,2-Dimethyl-3-hydroxypyrid-4-one (L1) has been given daily for 1-15 months to 13 transfusion dependent iron loaded patients </plain></SENT>
<SENT sid="1" pm="."><plain>No significant change occurred in liver, renal or cardiac function, ECG and radionucleotide angiocardiogram, in audiometry tests and in visual function and electrical retinography </plain></SENT>
<SENT sid="2" pm="."><plain>No skin <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rashes</z:e>, gastrointestinal symptoms and no neurological changes that could be detected clinically were observed </plain></SENT>
<SENT sid="3" pm="."><plain>Two of the patients died of their underlying diseases </plain></SENT>
<SENT sid="4" pm="."><plain>One patient had severe <z:hpo ids='HP_0001627'>cardiac abnormalities</z:hpo> before receiving L1 and died of <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> with <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> 5 weeks after stopping a 2-month course of L1 </plain></SENT>
<SENT sid="5" pm="."><plain>The other, a patient with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> suffered recurring <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> due to progression of the disease </plain></SENT>
<SENT sid="6" pm="."><plain>Joint and <z:hpo ids='HP_0003326'>muscle pains</z:hpo> occurred in five patients </plain></SENT>
<SENT sid="7" pm="."><plain>In two these disappeared despite continuing the drug; another patient developed swollen ankle joints which gradually resolved on stopping L1 therapy; a patient with underlying <z:hpo ids='HP_0002758'>osteoarthritis</z:hpo> complained of mild pain and stiffness in her knees which remained intermittent both on and off the drug while in the fifth patient peripheral small <z:hpo ids='HP_0001386'>joint swelling</z:hpo> and pain present before starting L1 improved with L1 therapy </plain></SENT>
<SENT sid="8" pm="."><plain>One patient, with <z:e sem="disease" ids="C1260899" disease_type="Disease or Syndrome" abbrv="BDS">Blackfan Diamond</z:e> <z:hpo ids='HP_0001903'>anaemia</z:hpo>, developed a Lw red cell antibody 6 months after commencing L1 </plain></SENT>
<SENT sid="9" pm="."><plain>This disappeared on stopping the drug and did not reappear </plain></SENT>
<SENT sid="10" pm="."><plain>She then developed severe <z:mp ids='MP_0000334'>agranulocytosis</z:mp> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> 6 weeks after recommencing L1 after 3 months discontinuation of the drug </plain></SENT>
<SENT sid="11" pm="."><plain>No other patient showed a change in granulocyte or platelet count </plain></SENT>
</text></document>